Timmaiah Chendrimada

Dr. Timmaiah Chendrimada brings in 12 years of drug discovery and development experience across therapy areas including cardiovascular and oncology obtained at GlaxoSmithKline (GSK) pharmaceuticals. He has led multiple pre-clinical programs and has experience with therapeutic entities including small molecules, antibodies, AAVs and RNA oligos.

Previously, at the Wistar Institute in Philadelphia, he worked on understanding RNA biochemistry, with an emphasis on the biogenesis and maturation of small RNAs. His research is published in high-profile journals including Nature, Cell, EMBO. Tim obtained his Ph.D. at the University of Georgia and has an MBA from Columbia Business School.